• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

8 all time lows in January, and another today $1.71









and down another 5% today to $1.61 . Get ready for Nasdaq non compliance delisting notice

Did investors got wind of Habib stopping all PR efforts?
That is probably the reason the stock is down: The Habib Factor.
It proves the point of the importance of having a good PR Function.
We should ask Habib to come back and not leave Acorda hanging.
 




















The PR effort was a total fiasco, never drove up stock price. It must have been Ron's idea. Wonder how much it cost.
THE PR EFFORT WAS WELL DONE AN AFFECTIVE! THE PR EFFORT DROVE SHARE PRICE UP ! THE BIG PHARMA WENT AFTER ACOR GOLDEN PIPELINE AN WITH EXTERNAL EVENTS TANK THE STOCK. PR WAS GREAT!
 




























So you were paid to drive the company into bankruptcy? That is the outcome. If you want to take credit, it wouldn’t surprise me.
The RAGS TO RICHES TO RAGS STORY WILL BE TOLD SOMEDAY ! THE STORY OF HOW A SMALL INNOVATIVE COMPANY WAS TARGETTED ! HOW A RICH PIPELINE WAS DRANED ! HOW HEROIC PR KEPT SHAREPRICE UP ! THE STORY MUST BE TOLD!